Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

Delayed Data
As of Jul 31
 -0.46 / -0.34%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 145.00, with a high estimate of 180.00 and a low estimate of 85.00. The median estimate represents a +7.41% increase from the last price of 135.00.

Analyst Recommendations

The current consensus among 26 polled investment analysts is to Hold stock in Vertex Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 42.75%
Growthannually 38.74%


Growthquarterly 57.68%
Growthannually 62.79%
Key to the earnings and sales forecast charts.